Showing results (5121-5130 of 10,388) with videos related to

Sort By:
Pageof 1,039
Vaccines|October 26, 2026
Route-Dependent Effects of Pre-Existing Anti-Ad5 Immunity on Systemic, Mucosal and Lymph Node B Cell Responses to an Ad5-Vectored VaccineWanru Zheng, Jingjia Xiang, Xinyang Guo, et al.
Vaccines|October 26, 2026
Immunological Challenges and Emerging Strategies in Dengue Virus Vaccine DevelopmentXuelian Ma, Mengyuan Zhao, Yaqun Xu, et al.
Vaccines|October 26, 2026
Indian Multidisciplinary Expert Opinions on the Use of 20-Valent Pneumococcal Conjugate Vaccine in AdultsParvaiz A Koul, Raja Dhar, Veeraraghavan Balaji, et al.
Vaccines|October 26, 2026
From Monovalent EV-A71 Vaccines to Multivalent Vaccines Against Hand, Foot and Mouth Disease in China: Development Progress, Evidence Gaps, and Translational ChallengesYi Zhang, Yu Gu, Zhi Li, et al.
Vaccines|October 26, 2026
Compliance with Two Vaccination Regimens of Freeze-Dried Human Rabies Vaccine (Vero Cell) and Influencing Factors in Hubei Province, ChinaDan Li, Haiyan Liang, Debao Li, et al.
Vaccines|October 26, 2026
Assessing the Status of and Impediments to Achieving the WHO Goal to Eliminate Viral Hepatitis B by 2030: A Scoping ReviewCharles Berabose, Ralf Clemens, Tatiana De Noronha, et al.
Vaccines|October 26, 2026
Age-Related Immune Response to Previous Smallpox Vaccination in Albanian Subjects and Cross-Reactivity Between Vaccinia Virus and Monkeypox Virus AntigensAdriana Manuka, Irsida Mehmeti, Antonia Radaelli, et al.
Vaccines|October 26, 2026
Double-Blind, Randomized, Phase 2a Study to Evaluate the Safety and Immunogenicity of OVX836, a Nucleoprotein-Based Universal Influenza Vaccine, Co-Administered with Fluarix Tetra® or Afluria Quad®Nicola Groth, Jacques Bruhwyler, Emilie Piat, et al.
Vaccines|October 26, 2026
Factors Associated with Intention to Receive the TAK-003 Dengue Vaccine Among Adults in Endemic Regions of Peru: A Cross-Sectional StudyJose Armando Gonzales-Zamora, Julieta Maribel Araoz-Salinas, Carlos Quispe-Vicuña, et al.
Vaccines|May 30, 2019
An HER2-Displaying Virus-Like Particle Vaccine Protects from Challenge with Mammary Carcinoma Cells in a Mouse ModelLisa Nika, Sara Cuadrado-Castano, Guha Asthagiri Arunkumar, et al.
Pageof 1,039